Ignite Creation Date:
2025-12-25 @ 1:40 AM
Ignite Modification Date:
2026-01-07 @ 2:07 PM
Study NCT ID:
NCT00447694
Status:
COMPLETED
Last Update Posted:
2021-06-14
First Post:
2007-03-13
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Cardiac T2* in Beta-thalassemia Patients on Deferasirox Treatment
Sponsor:
Novartis
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
CICL670AUS04
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None